Spine disc injection could ease back pain without surgery
Disease control
Recruiting now
This Phase 3 trial tests whether a single injection of IDCT (rebonuputemcel), a cell therapy, can safely reduce pain and disability in people with mild to moderate lumbar disc degeneration. About 162 adults with chronic low back pain will receive either the cell injection or a sh…
Phase: PHASE3 • Sponsor: DiscGenics, Inc. • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC